La cadena de opciones muestra datos clave de las opciones de acciones de Tempest Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Tempest Therapeutics..

Tempest Therapeutics (NASDAQ:TPST) Bolsa, Cadena de Opciones

Tempest Therapeutics

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics Inc

Piper Sandler analyst Christopher Raymond maintains ALX Oncology Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALXO#NASDAQ">ALXO</a>) with a Overweight and raises the price target from $8 to $9.

News

Price Target

Analyst Ratings

ALXO

Piper Sandler Maintains Overweight on ALX Oncology Holdings, Raises Price Target to $9

Stephens &amp; Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAT#NASDAQ">HCAT</a>) with a Equal-Weight and lowers the price target from $7 to $5.

HCAT

Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $5

<ul>
<li>TSLA</li>
<li>NVDA</li>
<li>MSTR</li>
<li>LUNR</li>
<li>WAR</li>
<li>BABA</li>
<li>GLD</li>
<li>CORN</li>
<li>AMD</li>
<li>WEN</li>
</ul>
Data From <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

BABA

CORN

LUNR

MSTR

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of March 6, 2025 (Via Swaggy Stocks)

Stephens &amp; Co. analyst John Campbell maintains Descartes Systems Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) with a Overweight and lowers the price target from $145 to $137.

DSGX

Stephens & Co. Maintains Overweight on Descartes Systems Gr, Lowers Price Target to $137

Victorias Secret &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) shares are trading lower premarket on Thursday after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44152215/victorias-secret-co-reports-fourth-quarter-2024-results" rel="noreferrer noopener">reported&nbsp;fourth-quarter&nbsp;results yesterday</a>.
Revenue rose&nbsp;1%&nbsp;year over year to&nbsp;$2.11&nbsp;billion, beating the consensus of&nbsp;$2.09 billion.
Total comparable sales for the quarter&nbsp;increased&nbsp;5%. Holiday results saw sales up in both Victoria&#8217;s Secret and PINK brands as well as Beauty business.
Adjusted operating income&nbsp;rose to&nbsp;$299&nbsp;million&nbsp;from&nbsp;$283&nbsp;million&nbsp;a year ago quarter.
In the fourth quarter of 2024, the company revised its accounting estimate which led to a cumulative change that increased net sales, gross margin, and operating income by approximately $26 million.
Adjusted EPS&nbsp;of&nbsp;$2.60 beat&nbsp;the consensus of&nbsp;$2.30, vs.&nbsp;guidance&nbsp;for&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/12/42365539/victorias-secret-lifts-fy24-guidance-after-strong-q3-sees-holiday-momentum" rel="noreferrer noopener">adjusted EPS of&nbsp;$2.00 –&nbsp;$2.30</a>.
CEO&nbsp;Hillary Super said, &#8220;Sales increased across most major merchandise categories, in our stores and digital channels, and in both our North America and International businesses. We won in the big moments of the quarter and gained more than our fair share of the traffic in the mall and online.&#8221;
Related Read: <a target="_blank" href="https://www.benzinga.com/25/01/43317266/victorias-secret-shares-drop-following-cfo-transition-announcement-whats-going-on" rel="noreferrer noopener">Victoria&#8217;s Secret Shares Drop Following CFO Transition Announcement</a>
&#8220;As we look forward to 2025 and the future, we recognize there are near-term headwinds and ongoing uncertainty in the macro environment which we will manage aggressively while also working to build upon our solid foundation, realize the full potential of our brands and drive long-term, sustainable growth.&#8221;
Outlook: For the&nbsp;first quarter, Victoria&#8217;s Secret expects&nbsp;net sales of&nbsp;$1.30 billion &#8211; $1.33 billion vs. consensus of $1.39 billion&nbsp;and adjusted operating <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">income of $10 million &#8211; $30 million</a>.
Victoria&#8217;s Secret expects FY25 net sales of $6.2 billion &#8211; $6.3 billion&nbsp;vs. consensus of $6.34 billion and adjusted operating income of $300 million to $350 million.
Price Action: VSCO shares are down 5.45% at $21.00 premarket at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44146094/wall-street-awaits-trumps-tariff-decision-digests-mixed-economic-data-whats-driving-markets-wednesday" target="_blank" rel="noreferrer noopener">Wall Street Awaits Trump&#8217;s Tariff Decision, Digests Mixed Economic Data: What&#8217;s Driving Markets Wednesday?</a></li>
</ul>
Photo via Shutterstock.

Earnings

Equities

Large Cap

Guidance

Movers

VSCO

Victoria's Secret Delivers Solid Q4 Results, But CEO Warns Of 'Near-Term Headwinds'

Wedbush analyst Daniel Ives maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Outperform and lowers the price target from $360 to $300.

Wedbush Maintains Outperform on MongoDB, Lowers Price Target to $300

Wedbush analyst Daniel Ives maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Outperform and raises the price target from $230 to $240.

Wedbush Maintains Outperform on Zscaler, Raises Price Target to $240

WIIM

Superior Industries International shares are trading higher after the company reported a Q4 EPS beat.

Marriott International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) has outperformed the market over the past 15 years by 4.75% on an annualized basis producing an average annual return of 16.15%. Currently, Marriott International has a market capitalization of $73.89 billion. 
Buying $100 In MAR: If an investor had bought $100 of MAR stock 15 years ago, it would be worth $956.94 today based on a price of $268.00 for MAR at the time of writing.
<h3>Marriott International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741270509_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Marriott International 15 Years Ago Would Be Worth This Much Today

Wedbush analyst Seth Basham maintains Sleep Number (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNBR#NASDAQ">SNBR</a>) with a Neutral and lowers the price target from $18 to $12.

SNBR

Wedbush Maintains Neutral on Sleep Number, Lowers Price Target to $12

Taiwan President&nbsp;Lai Ching-te&nbsp;and <a target="_blank" href="https://www.benzinga.com/topic/tsmc" rel="noreferrer noopener">contract chipmaker</a> Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) Chair and CEO&nbsp;C.C. Wei&nbsp;held a press briefing on Thursday at 5 pm local time in Taipei, Bloomberg <a target="_blank" href="http://bloomberg.com/news/articles/2025-03-06/taiwan-s-president-tsmc-ceo-plan-to-hold-briefing-at-5-p-m?sref=TBDibEcD" rel="noreferrer noopener">reports</a>.
Wei said it was &#8220;not afraid&#8221; of losing Washington&#8217;s subsidies for its massive U.S. investments, the Financial Times <a target="_blank" href="https://www.ft.com/content/dd6d466d-dd2a-4345-879b-c9af7f7d47d2" rel="noreferrer noopener">reports</a> from the joint press conference. The stock is trading lower on Thursday.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44147564/box-sees-strong-q4-bookings-and-ai-expansion-but-margin-outlook-prompts-analyst-adjustments" rel="noreferrer noopener">Box Sees Strong Q4 Bookings And AI Expansion, But Margin Outlook Prompts Analyst Adjustments</a>
Earlier this week, the Taiwanese contract chipmaker announced plans to&nbsp;invest&nbsp;another $100 billion in its U.S. facilities in addition to its existing investment of $65 billion.
President Donald Trump has been critical of Taiwan in his campaign for allegedly stealing the U.S. semiconductor position and running massive trade deficits with the country. Trump threatened <a target="_blank" href="https://www.benzinga.com/25/03/44147370/taiwan-semiconductor-caught-between-us-tariff-threats-and-taiwans-push-to-keep-advanced-chip-tech" rel="noreferrer noopener">retaliatory tariffs against</a> the island country, which relies on the U.S. for military backing against a China invasion.
Any additional U.S. investment made by TSMC would require Taiwan&#8217;s government&#8217;s approval. Taiwan maintained that the country would continue to be the key advanced semiconductor headquarters in response to reports indicating it was migrating its advanced technology to the U.S. under duress.
Trump&nbsp;also suggested scrapping&nbsp;U.S. subsidies to chipmakers to build fabs in the country to boost its semiconductor position.
In a separate update, Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) chief Cristiano Amon hailed Taiwan Semiconductor&#8217;s U.S. investment and <a target="_blank" href="https://www.cnbc.com/2025/03/04/qualcomm-ceo-welcomes-tsmc-100-billion-investment-in-us-chipmaking.html" rel="noreferrer noopener">told</a> CNBC that it would help diversify chipmaking locations. He noted that longer-term technology trends would outweigh any short-term uncertainty regarding Trump&#8217;s tariffs.
Amon told CNBC that some of Qualcomm&#8217;s chips are already manufactured in Taiwan Semiconductor&#8217;s existing plants in Arizona, and the company will eventually produce more semiconductors in the U.S.
Amon highlighted upgrades for AI smartphones, AI PCs, and cars becoming computers as key technology trends likely to support Qualcomm&#8217;s business in the long term over the short-term tariff uncertainty.
<a target="_blank" href="https://www.benzinga.com/25/03/44103610/taiwan-semiconductor-doubles-down-on-us-chipmaking-165-billion-investment-set-to-reshape-tech-jobs" rel="noreferrer noopener">IDC expects the</a> Taiwanese contract chipmaker&nbsp;to command a 67% share of the global foundry market in 2025.
Price Action:&nbsp;TSM stock is down 2.87% at $178.99 premarket at the last check Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44148252/intuit-gains-analyst-confidence-with-strong-business-trends-higher-pricing-power-and-market-stickiness" target="_blank" rel="noreferrer noopener">Intuit Under-performance Has Stemmed From Valuation Reset, Analyst Upgrades Stock</a></li>
</ul>
Photo by Sundry Photography on Shutterstock

Asia

Government

Regulations

Emerging Markets

Tech

Media

QCOM

Taiwan Semiconductor CEO, Taiwan President To Discuss $100 Billion US Expansion, 'Not Afraid' Of Losing US Subsidies

ELAB

PMGC Holdings shares are trading lower after the company announced a 1-for-7 reverse stock split to mantain Nasdaq listing.

Piper Sandler analyst David Amsellem maintains Indivior (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDV#NASDAQ">INDV</a>) with a Overweight and lowers the price target from $16 to $13.

INDV

Piper Sandler Maintains Overweight on Indivior, Lowers Price Target to $13

Wedbush analyst Seth Basham reiterates Dick's Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) with a Neutral and maintains $215 price target.

Reiteration

Wedbush Reiterates Neutral on Dick's Sporting Goods, Maintains $215 Price Target

IPOs

ADVB

Advanced Biomed Inc. IPO Of 1.64M Shares Priced At $4/Share

Wedbush analyst David Nierengarten reiterates Fate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) with a Neutral and maintains $5 price target.

FATE

Wedbush Reiterates Neutral on Fate Therapeutics, Maintains $5 Price Target

Macro Economic Events

Economics

Federal Reserve

Fed's Harker Says Worried More And More About Factors That Could Threaten Dollar Reserve Status, Says Business And Consumer Confidence Is Waning, Which Is Not Good

Michael Saylor, executive chairman of Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), suggested on Thursday that the United States plans to purchase 1 million Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to establish a strategic reserve, aligning with a framework outlined in the bill <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42601193/senator-lummis-introduces-strategic-bitcoin-reserve-proposal">proposed by senator</a> Cynthia Lummis (R-Wyo.)
He was <a href="https://x.com/Vivek4real_/status/1897398288502100068">speaking </a>in a Fox Business interview, ahead of a White House Crypto Summit scheduled for Friday, <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44125213/white-house-crypto-summit-to-feature-roundtable-with-industry-leaders-including-michael-saylor">where Saylor will participate. </a>
What Happened: Saylor emphasized a deliberate acquisition process over four years, leveraging the government's existing 200,000 Bitcoin holdings, valued at approximately $17 billion at current prices, to build the reserve.
Saylor, whose company holds over 500,000 Bitcoin—about 2.4% of the global supply—provided insight into the proposed strategy. 
"The Lummis bill has laid out the idea of acquiring Bitcoin strategically over four years, just consistently day by day, in order to reach a million Bitcoin target," he said, noting the involvement of a 12-member presidential working committee, including industry leaders, Senate, and House representatives. 
He clarified that the financing details remain undecided but stressed transparency as key to managing market impact. 
"The most responsible thing would be to go slow and steady and deliberate with clear telegraphing and transparency," Saylor added, addressing concerns about price volatility as supply decreases.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44148430/bitscrunch-acquires-nidum-ai-to-build-decentralized-ai-compute-network">BitsCrunch Acquires Nidum AI To Build Decentralized AI Compute Network</a>
The executive framed Bitcoin as "digital property" and a savings mechanism for Americans, drawing parallels to historical land acquisitions like the Louisiana Purchase. 
"If you think of Bitcoin as property in cyberspace… the logic behind a Bitcoin strategic reserve is not so much you're storing up Bitcoin, it's really that you're taking control of planting the flag in cyberspace," he explained. 
Saylor advocated for a focus on Bitcoin alone in the reserve, citing its status as the "universally agreed upon foundational asset" due to its issuer-less nature, though he acknowledged the need for a broader digital asset framework to support currencies, securities, and tokens.
What&#8217;s Next: Saylor addressed skepticism from Bitcoin's early adopters, who value its independence from government.
"Satoshi gave us a protocol for prosperity… it's logical that a country that is interested in economic empowerment and prosperity is going to adopt Bitcoin," he said, suggesting national adoption aligns with individual and corporate use. 
As he prepares for the summit, Saylor advised President Trump to prioritize clarity in asset classification and a progressive, transparent acquisition process, reinforcing his vision of U.S. leadership in the digital economy.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44148294/robinhood-ceo-vlad-tenev-expects-crypto-rails-to-become-the-foundation-of-stock-trading">Robinhood CEO Vlad Tenev Expects &#8216;Crypto Rails&#8217; To Become The Foundation Of Stock Trading</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Michael Saylor Hints US Will Buy 1 Million Bitcoin For Strategic Reserve

Politics

General

House Speaker Johnson Says Hopes To Hold Continuing Resolution Vote On Tuesday, Expects Passage

GRND

Grindr shares are trading lower. The company reported Q4 financial results.

Health Care

Press Releases

Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tempest Extends Limited Duration Stockholder Rights Plan

Contracts

Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial

Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma

Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update

Tempest to Participate in the Piper Sandler 36th Annual  Healthcare Conference

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Comments

Tempest Therapeutics

Tempest Therapeutics (TPST) Opciones

Tempest Therapeutics (NASDAQ:TPST) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL